Taro announces buyback plan

Sun Pharmaceutical Industries rose after the company's unit Taro Pharmaceutical announced the start of a tender offer to buy back up to $200 million of its ordinary shares.
Share this Video
appinstlBnr
Open in App
Success
This article has been saved